image
Healthcare - Biotechnology - NASDAQ - US
$ 0.1311
-6.36 %
$ 24.5 M
Market Cap
0.0
P/E
INCOME STATEMENT
7.77 M REVENUE
0.00%
-118 M OPERATING INCOME
-5.61%
-117 M NET INCOME
-5.84%
EFFICIENCY
Earnings Waterfall Tonix Pharmaceuticals Holding Corp.
image
Revenue 7.77 M
Cost Of Revenue 4.74 M
Gross Profit 3.03 M
Operating Expenses 121 M
Operating Income -118 M
Other Expenses -1.72 M
Net Income -117 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008
REVENUE
Revenue 7.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 4.7 112.1 92.3 50.5 28.8 26.3 21.3 39.0 48.2 27.7 10.9 6.7 3.4 0 17 K 7.11 K
Gross Profit 3.0 (112.1) (92.3) (50.5) (28.8) (26.3) (21.3) (39.0) (48.2) (27.7) (10.9) (6.7) (3.4) 0 17 K 7.11 K
OPERATING INCOME
Operating Expenses 121.4 112.1 92.3 50.5 28.8 26.3 21.3 39.0 48.2 27.7 10.9 6.7 3.4 17.7 K 13.9 K 14 K
Selling, General and Administrative Expenses 34.8 30.2 23.5 14.4 10.6 8.8 7.9 10.4 12.7 9.0 6.2 4.1 2.2 13.7 K 13.9 K 14 K
Research and Development Expenses 86.7 81.9 68.8 36.2 18.2 17.6 13.3 28.5 35.5 18.6 4.7 2.6 1.2 0 0 0
Operating Income (118.4) (112.1) (92.3) (50.5) (28.8) (26.3) (21.3) (39.0) (48.2) (27.7) (10.9) (6.7) (3.4) 17.7 K 30.9 K 21.1 K
PRE-TAX INCOME
Interest Income Expense 0 (7.9) 0 0 0 0 0 0 0 0 4 K 1.6 91.6 K 0 0 0
Total Other Income 1.7 1.9 25 K 48 K 0.2 0.2 0.2 0.1 0.1 40 K 4 K (2.8) 91.6 K (1.9) 0 0
Pre-Tax Income (116.7) (110.2) (92.3) (50.5) (28.6) (26.1) (21.1) (38.8) (48.1) (27.6) (10.9) (9.4) (3.5) 0 0 0
NET INCOME
Tax Provision 0 4.8 75 K 75 K (0.2) 0.2 70 K (0.2) (0.2) 36 K 17 K 1.6 3.4 17.7 K 30.9 K 21.1 K
Net Income (116.7) (116.9) (92.3) (52.2) (31.1) (29.4) (21.1) (38.8) (48.1) (27.6) (10.9) 9.45 K (3.5) 17.7 K 30.9 K 21.1 K
EPS 219 640 1.62 K 3.53 K 0 0 0 0 0 0 0 0 (0.6) 17.7 K 30.9 K 21.1 K